1. Scrip

Korea’s Ilyang Pharm, LegoChem Boosted By Anti-Cancer Therapy Deals

 
• By Jung Won Shin

South Korean pharmas advance in the oncology space as Ilyang Pharm lets Colombia's Biopas sell its novel leukemia therapy Supect in 10 Latin American countries, while LegoChem Biosciences links with Fosun Pharma for development and commercialization of its antibody-drug conjugate as an anticancer therapy for the Greater China region.

SEOUL - Ilyang Pharmaceutical Co. and LegoChem Biosciences Inc. have reached license agreements with foreign pharma firms for anti-cancer medicines, underscoring the rising recognition South Korea’s oncology drug technologies are receiving in global markets.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from South Korea

More from Focus On Asia